← back to search

Kerstin Jurk

Johannes Gutenberg University Mainz · DE
Area of research
Internal Medicine · Hematology
Research interest
Research focused on Kidney disease and Platelet, with related work in Thrombus, Tissue factor, Urokinase receptor. Notable publications include 'Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations', 'Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1', and 'Paraoxonase-2 regulates coagulation activation through endothelial tissue factor'.
h-index
citations
360
works
10
NIH funding
primary concept
email

Recent publications

Suppressed ORAI1-STIM1-dependent Ca2+ entry by protein kinase C isoforms regulating platelet procoagulant activity
Journal of Biological Chemistry 2024cited by 10position: middledoi
Protein Disulfide Isomerase and Extracellular Adherence Protein Cooperatively Potentiate Staphylococcal Invasion into Endothelial Cells
Microbiology Spectrum 2023cited by 3position: middledoi
Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism
Thrombosis Research 2022cited by 4position: lastdoi
Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS
Scientific Reports 2020cited by 27position: middledoi
Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1
Circulation Research 2019cited by 70position: middledoi
Paraoxonase-2 regulates coagulation activation through endothelial tissue factor
Blood 2018cited by 52position: middledoi
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
International Journal of Nephrology and Renovascular Disease 2017cited by 126position: middledoi
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
BMC Pharmacology and Toxicology 2017cited by 16position: middledoi
Antiplatelet Agents and Anticoagulants in Patients with Chronic Kidney Disease - from Pathophysiology to Clinical Practice
Current Pharmaceutical Design 2016cited by 8position: lastdoi
Urokinase Receptor Mediates Osteogenic Differentiation of Mesenchymal Stem Cells and Vascular Calcification via the Complement C5a Receptor
Stem Cells and Development 2013cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fiorella A. Solari · University of Aberdeen2 papers (2020–2024)Johan W. M. Heemskerk · Leiden University Medical Center2 papers (2020–2024)Barbara Zieger · University of Freiburg2 papers (2020–2024)Albert Sickmann · University of Duisburg-Essen2 papers (2020–2024)Stavros Konstantinides · Agia Olga Hospital2 papers (2019–2022)Paola E. J. van der Meijden · Maastricht University Medical Centre2 papers (2020–2022)Nadine J.A. Mattheij · Radboud University Nijmegen2 papers (2020–2024)Jens Lutz · Johannes Gutenberg University Mainz2 papers (2016–2017)Thomas Münzel · Medical Genetics Center2 papers (2019–2022)Sergey Tkachuk · Medizinische Hochschule Hannover1 papers (2013–2013)Katrin Schäfer · Johannes Gutenberg University Mainz1 papers (2019–2019)Markus Nagler · Carl Zeiss (Germany)1 papers (2022–2022)Rajinikanth Gogiraju · Johannes Gutenberg University Mainz1 papers (2019–2019)Inna Dumler · Medizinische Hochschule Hannover1 papers (2013–2013)Wolfram Ruf · Johannes Gutenberg University Mainz1 papers (2018–2018)Kathrin Schwierczek · Johannes Gutenberg University Mainz1 papers (2018–2018)Hermann Haller · College of the Atlantic1 papers (2013–2013) · 1 papers (2024–2024)Lisa Spiecker · Johannes Gutenberg University Mainz1 papers (2018–2018)Margret Patecki · Medizinische Hochschule Hannover1 papers (2013–2013)